市場調查報告書

注射型藥物輸送設備的全球市場的未來預測

Injectable Drug Delivery Market - Forecast (2020 - 2025)

出版商 IndustryARC 商品編碼 622518
出版日期 內容資訊 英文 101 Pages
商品交期: 2-3個工作天內
價格
注射型藥物輸送設備的全球市場的未來預測 Injectable Drug Delivery Market - Forecast (2020 - 2025)
出版日期: 2020年03月11日內容資訊: 英文 101 Pages
簡介

本報告提供全球注射型藥物輸送設備的市場相關分析,提供整體市場結構和背景情況,主要的推動及阻礙市場要素,各產品種類 (設備,劑型)·各疾病·各地區的市場趨勢預測,市場競爭情勢,近來的資本交易·策略發展的動向,主要企業的簡介等相關調查。

第1章 市場概要

第2章 摘要整理

第3章 市場環境

  • 市場佔有率分析
  • 比較分析
    • 產品的互相比較
    • 終端用戶的簡介
    • 專利分析
    • 前五名公司的財務分析

第4章 全球注射式藥物輸送設備市場:對市場的影響要素

  • 推動市場要素
  • 阻礙市場要素
  • 市場課題
  • 市場向心力:波特的五力分析

第5章 全球注射式藥物輸送設備市場:策略分析

  • 價值鏈分析
  • 市場機會分析
  • 產品/市場生命週期分析

第6章 全球注射式藥物輸送設備市場:各類型

  • 醫藥品的劑型方法
  • 不同設備
    • 傳統的設備
    • 自動注射設備
    • 自行注射設備
    • 筆型注射器
    • 無針頭注射設備
  • 其他

第7章 全球注射式藥物輸送設備市場:疾病類別

  • 貧血症
  • 糖尿病
  • 多發性硬化症
  • 風濕
  • 克隆氏症
  • 其他

第8章 全球注射式藥物輸送設備市場:各地區

  • 簡介
  • 北美 (加拿大,海地,墨西哥,美國等)
  • 中南美 (阿根廷,巴西,智利,哥倫比亞,委內瑞拉等)
  • 歐洲 (德國,法國,義大利,俄羅斯,西班牙,土耳其,英國等)
  • 亞太地區 (孟加拉,中國,印度,尼泊爾,斯里蘭卡,新加坡,馬來西亞等)
  • 其他的國? (RoW)

第9章 市場熵 (市場變化的方向性)

  • 新產品的銷售
  • 企業合併·收購 (M&A),事業聯盟·合作,合資企業 (JV)

第10章 企業簡介 (概要,財務分析,SWOT分析,近幾年趨勢,產品系列)

  • Becton Dickinson and Company (BD)
  • Baxter International Inc.
  • Consort Medical PLC
  • Crossject SA
  • Eli Lilly and Company
  • Elcam Medical
  • Novo Nordisk
  • Owen Mumford Ltd
  • Sanofi
  • Schott AG
  • Terumo Corporation
  • Ypsomed Holding AG
  • 其他

第11章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HCR 0023

Drug Delivery Market Overview:

Annually, medical error causes 250,000 deaths in the US, which is the third leading cause of death in the North American region.[1] Medical treatment based on medication targeted to treat one's bodily disorder can produce severe repercussions to other unintended body parts. Albeit the curative efficacy for treating cancer, chemotherapy, for instance, causes several side effects such as headaches, blood disorders, heart disorders, and various other post health issues. Modern technology and biological advancement is set to overcome these challenges to effective medication with drug delivery systems owing to its effective therapeutic effects. Specialized in actively treating any particular malfunctioning area in the body without adversely affecting any other bodily functions, these targeted therapies have become an alternative to many conventional medical treatments.

The global drug delivery market value attained $17.50 billion in the year 2018. Drug delivery procedure includes oral, inhalation, injection, and transdermal absorption of the drug to the targeted part, resultantly uplifting the treatment methods for various diseases. The prominent benefits of drug delivery in the associated healthcare facilities around the world has propelled the global drug delivery market. As per the evaluation, the huge demand for the drug delivery devices generated by the increasing population will grow at a compound annual growth rate (CAGR) of 7.20% through to 2019-2025.

Drug Delivery Market Outlook:

The drug delivery provided in the medical and healthcare sector include various types of advanced technological devices systems such as intrauterine implants, targeted drug delivery, polymeric drug delivery, and many others. The increasing number of healthcare facilities and the widespread chronic diseases are some of the major factors influencing the drug delivery market growth in North America, which held a huge global market share of 36% in 2018, and the demand will have an unprecedented growth in the foreseeable future. The possible ability of drug delivery to substitute therapeutic treatment, which pose risks of affecting on non-targeted body parts induces wide acceptance of this system by the hospitals and patients. The key application of drug delivery in conventional injection devices will have an effective CAGR of 6.70% through to 2025.

Drug Delivery Market Growth Drivers:

  • Increasing incidences of chronic disease such as cancer across the world is majorly driving the global drug delivery market owing to the effective and targeted drug release along with minimal side-effects on the body.
  • Rising population of the old-age majority demands greater supply of generic drugs and doses. Growing age accompanies several diseases resulting in an upsurge of the drug delivery market.
  • Incrementing global biologics and biosimilar market is inducing a positive influence on the global drug delivery market owing to a lucrative market revenue.
  • New innovations, technological advancement, and promotion of new products propelled by the key manufacturers in the global market, wide scope of development and profitable outcome is accomplished by the drug delivery market.

Drug Delivery Market Challenges:

The nanoparticles of drug delivery systems are made up of certain substances which reacts with the cellular membranes resulting in morphological changes. Moreover, certain drug delivery devices are partially or completely insoluble in nature becoming a barrier in the blood streams. This may lead to several other health issues creating severe problems. Medical researches executed and other biotechnological advancements conducted by the pharmaceutical industries are constantly limiting these drawbacks through their innovative and cost-efficient drug delivery systems.

Drug Delivery Market Key Players:

The pioneers in the global drug delivery market include companies like Becton, Dickinson and Company, Baxter International, Pfizer, Gerresheimer AG, Schott AG, Eli Lilly and Company, and Terumo Corporation, and others.

Dickinson and Company is an American based leading medical technology company delivers various ergonomic drug delivery systems including prefillabe syringes, self-injection systems, safety and shielding devices to more than 500 companies, which reduces pain and enhances the delivery span to ultimately provide the patients a healthy medication.

Drug Delivery Market Trends:

  • Advanced Prodrug Implants

Prodrug therapy offers two-step solution for cancerous cells and is used as an alternative treatment to chemotherapy. Antibodies are delivered to the particular cancer sites in the body, thereby targeting the enzymes of the cancer cells and releasing prodrug to kill the cancer cells without affecting any normal cells.

  • Chip-Based Drug Delivery

Microchip drug delivery is an advanced medical technology which when injected into a body system or consumed orally remains inside the body and releases drug doses at regular and fixed intervals over a great time span. Without any interventions of the bearer, this modern drug delivery system is gaining large scale demand from different end-users owing to its potential benefits in treating chronic diseases.

  • Cellular Delivery Technology

The potentiality of cells as carrier of drugs is exploited by modern medical science and technology. Cellular drug delivery emerges as an alternative to nano and micro drug delivery particles with efficiency in the treatment of HIV, cancer, cardiovascular diseases, and other body abnormalities.

Drug Delivery Market Research Scope:

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the Drug Delivery Market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types of drug delivery in Drug Delivery Market, and their specific applications in different areas.

1. Injectable Drug Delivery Market - Overview

  • 1.1. Definitions and Scope

2. Injectable Drug Delivery Market - Executive summary

  • 2.1. Market Revenue, Market Size and Key Trends by Company
  • 2.2. Key Trends by type of Application
  • 2.3. Key Trends segmented by Geography

3. Injectable Drug Delivery Market

  • 3.1. Comparative analysis
    • 3.1.1. Product Benchmarking - Top 10 companies
    • 3.1.2. Top 5 Financials Analysis
    • 3.1.3. Market Value split by Top 10 companies
    • 3.1.4. Patent Analysis - Top 10 companies
    • 3.1.5. Pricing Analysis

4. Injectable Drug Delivery Market Forces

  • 4.1. Drivers
  • 4.2. Constraints
  • 4.3. Challenges
  • 4.4. Porters five force model
    • 4.4.1. Bargaining power of suppliers
    • 4.4.2. Bargaining powers of customers
    • 4.4.3. Threat of new entrants
    • 4.4.4. Rivalry among existing players
    • 4.4.5. Threat of substitutes

5. Injectable Drug Delivery Market - Strategic analysis

  • 5.1. Value chain analysis
  • 5.2. Opportunities analysis
  • 5.3. Product life cycle
  • 5.4. Suppliers and distributors Market Share

6. Injectable Drug Delivery Market - Market By Delivery Devices (Market Size -$Million / $Billion)

  • 6.1. Market Size and Market Share Analysis
  • 6.2. Application Revenue and Trend Research
  • 6.3. Product Segment Analysis
    • 6.3.1. Market Overview
    • 6.3.2. Conventional Injection Devices Market
    • 6.3.3. Self-Injection Devices Market
    • 6.3.4. Auto Drug Injecting Devices
      • 6.3.4.1. By Drug Loading
      • 6.3.4.1.1. Prefilled Auto Injectors
      • 6.3.4.1.2. Fillable Auto Injectors
      • 6.3.4.1.3. By User Intervention
      • 6.3.4.1.4. Automated Auto Injectors
      • 6.3.4.1.5. Manual Auto Injectors
      • 6.3.4.1.6. By Design
      • 6.3.4.1.6.1. Standard Auto Injectors
      • 6.3.4.1.6.2. Customized Auto Injectors
      • 6.3.4.1.7. By Reusability
      • 6.3.4.1.7.1. Disposable Auto Injectors
      • 6.3.4.1.7.2. Reusable Auto Injectors
    • 6.3.5. Pen Injectors
      • 6.3.5.1. By Product
      • 6.3.5.1.1. Single Chamber Pen Injectors
      • 6.3.5.1.2. Dual Chamber Pen Injectors
      • 6.3.5.2. By Reusability
      • 6.3.5.2.1. Disposable Pen Injectors
      • 6.3.5.2.2. Reusable Pen Injectors
      • 6.3.5.3. By Design
      • 6.3.5.3.1. Standardized Pen Injectors
      • 6.3.5.3.2. Customized Pen Injectors
    • 6.3.6. Needle Free Drug Injection Devices
      • 6.3.6.1. By Drug Loading
      • 6.3.6.1.1. Prefilled Needle Free Injectors
      • 6.3.6.1.2. Fillable Needle Free Injectors
      • 6.3.6.2. By Technology
      • 6.3.6.2.1. Jet-Based Needle-Free Injectors
      • 6.3.6.2.2. Spring-Based Needle-Free Injectors
      • 6.3.6.2.3. Laser-Based Needle Free Injectors
      • 6.3.6.2.4. Vibration-Based Needle Free Injectors
      • 6.3.6.3. By Reusability
      • 6.3.6.3.1. Disposable Needle Free Injectors
      • 6.3.6.3.2. Reusable Needle Free Injectors
    • 6.3.7. Conventional Drug Injection Devices
      • 6.3.7.1. By Reusability
      • 6.3.7.1.1. Disposable Injection Devices
      • 6.3.7.1.2. Reusable Injection Devices
      • 6.3.7.2. By Material
      • 6.3.7.2.1. Glass Based Injectors
      • 6.3.7.2.2. Plastic Based Injectors
      • 6.3.7.3. By Drug Loading
      • 6.3.7.3.1. Prefilled Injection Devices
      • 6.3.7.3.2. Fillable Injection Device
    • 6.3.6. Wearable injectors
    • 6.3.9. Safety syringes
    • 6.3.10. Integrated safety syringes
    • 6.3.11. Patch injectors
    • 6.3.12. Subcutaneous infusion devices

7. Injectable Drug Delivery Market - By Drug Formulations (Market Size -$Million / $Billion)

  • 7.1. Conventional Drug Delivery Formulations
    • 7.1.1. Injectable Drug Delivery Formulation Solutions
    • 7.1.2. Reconstituted Drug Delivery Formulation Solutions
  • 7.2. Novel Drug Delivery Formulation Solutions
    • 7.2.1. Liposomal Systems
    • 7.2.2. Microspheres
    • 7.2.3. Nanoparticles
    • 7.2.4. Polymeric Micelles
    • 7.2.5. Others

8. Injectable Drug Delivery Market - By Therapeutic Areas (Market Size -$Million / $Billion)

  • 8.1. Auto-Immune Diseases
    • 8.1.1. Multiple Sclerosis
    • 8.1.2. Rheumatoid Arthritis
    • 8.1.3. Crohn's Diseases
    • 8.1.4. Psoriasis
    • 8.1.5. Others
  • 8.2. Hormonal Disorders
    • 8.2.1. Diabetes
    • 8.2.2. Anemia
    • 8.2.3. Reproductive Health Diseases
    • 8.2.4. Osteoporosis
    • 8.2.5. Growth Hormone Deficiency
    • 8.2.6. Antithrombotic Therapy
  • 8.3. Orphan or Rare Diseases
  • 8.4. Oncology
  • 8.5. Others
    • 8.5.1. Pain Management
    • 8.5.2. Hepatitis C
    • 8.5.3. Allergies
    • 8.5.4. Aesthetic Treatment

9. Injectable Drug Delivery Market - By application (Market Size -$Million / $Billion)

  • 9.1. Diabetes
  • 9.2. Cardiovascular diseases
  • 9.3. Autoimmune diseases
  • 9.4. Hormones replacement
  • 9.5. Neurology addiction
  • 9.6. Respiratory diseases
  • 9.7. others

10. Injectable Drug Delivery - By End User(Market Size -$Million / $Billion)

  • 10.1. Segment type Size and Market Share Analysis
  • 10.2. Application Revenue and Trends by type of Application
  • 10.3. Application Segment Analysis by Type
    • 10.3.1. Homecare
    • 10.3.2. Professional care
      • 10.3.2.1. Hospitals
      • 10.3.2.2. clinics

11. Injectable Drug Delivery - By Geography (Market Size -$Million / $Billion)

  • 11.1. Injectable Drug Delivery Market - North America Segment Research
  • 11.2. North America Market Research (Million / $Billion)
    • 11.2.1. Segment type Size and Market Size Analysis
    • 11.2.2. Revenue and Trends
    • 11.2.3. Application Revenue and Trends by type of Application
    • 11.2.4. Company Revenue and Product Analysis
    • 11.2.5. North America Product type and Application Market Size
      • 11.2.5.1. U.S.
      • 11.2.5.2. Canada
      • 11.2.5.3. Mexico
      • 11.2.5.4. Rest of North America
  • 11.3. Injectable Drug Delivery - South America Segment Research
  • 11.4. South America Market Research (Market Size -$Million / $Billion)
    • 11.4.1. Segment type Size and Market Size Analysis
    • 11.4.2. Revenue and Trends
    • 11.4.3. Application Revenue and Trends by type of Application
    • 11.4.4. Company Revenue and Product Analysis
    • 11.4.5. South America Product type and Application Market Size
      • 11.4.5.1. Brazil
      • 11.4.5.2. Venezuela
      • 11.4.5.3. Argentina
      • 11.4.5.4. Ecuador
      • 11.4.5.5. Peru
      • 11.4.5.6. Colombia
      • 11.4.5.7. Costa Rica
      • 11.4.5.8. Rest of South America
  • 11.5. Injectable Drug Delivery - Europe Segment Research
  • 11.6. Europe Market Research (Market Size -$Million / $Billion)
    • 11.6.1. Segment type Size and Market Size Analysis
    • 11.6.2. Revenue and Trends
    • 11.6.3. Application Revenue and Trends by type of Application
    • 11.6.4. Company Revenue and Product Analysis
    • 11.6.5. Europe Segment Product type and Application Market Size
      • 11.6.5.1. U.K
      • 11.6.5.2. Germany
      • 11.6.5.3. Italy
      • 11.6.5.4. France
      • 11.6.5.5. Netherlands
      • 11.6.5.6. Belgium
      • 11.6.5.7. Spain
      • 11.6.5.8. Denmark
      • 11.6.5.9. Rest of Europe
  • 11.7. Injectable Drug Delivery - APAC Segment Research
  • 11.8. APAC Market Research (Market Size -$Million / $Billion)
    • 11.8.1. Segment type Size and Market Size Analysis
    • 11.8.2. Revenue and Trends
    • 11.8.3. Application Revenue and Trends by type of Application
    • 11.8.4. Company Revenue and Product Analysis
    • 11.8.5. APAC Segment - Product type and Application Market Size
      • 11.8.5.1. China
      • 11.8.5.2. Australia
      • 11.8.5.3. Japan
      • 11.8.5.4. South Korea
      • 11.8.5.5. India
      • 11.8.5.6. Taiwan
      • 11.8.5.7. Malaysia

12. Injectable Drug Delivery Market - Entropy

  • 12.1. New product launches
  • 12.2. M&A's, collaborations, JVs and partnerships

13. Injectable Drug Delivery Market Company Analysis

  • 13.1. Market Share, Company Revenue, Products, M&A, Developments
  • 13.2. Terumo Corp
  • 13.3. Schott AG
  • 13.4. SHL group
  • 13.5. Owen Mumford ltd
  • 13.6. Sanofi
  • 13.7. Novo nordix
  • 13.8. Company 8
  • 13.9. Company 9 and more

"*Financials would be provided on a best efforts basis for private companies"

14. Injectable Drug Delivery Market - Appendix

  • 14.1. Abbreviations
  • 14.2. Sources

15. Injectable Drug Delivery Market - Methodology

  • 15.1. Research Methodology
    • 15.1.1. Company Expert Interviews
    • 15.1.2. Industry Databases
    • 15.1.3. Associations
    • 15.1.4. Company News
    • 15.1.5. Company Annual Reports
    • 15.1.6. Application Trends
    • 15.1.7. New Products and Product database
    • 15.1.8. Company Transcripts
    • 15.1.9. R&D Trends
    • 15.1.10. Key Opinion Leaders Interviews
    • 15.1.11. Supply and Demand Trends